These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 3924605

  • 1. Protection against fatal Pseudomonas aeruginosa sepsis by immunization with smooth and rough lipopolysaccharides.
    Cryz SJ, Meadow PM, Fürer E, Germanier R.
    Eur J Clin Microbiol; 1985 Apr; 4(2):180-5. PubMed ID: 3924605
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization.
    Lang AB, Fürer E, Senyk G, Larrick JW, Cryz SJ.
    Hum Antibodies Hybridomas; 1990 Apr; 1(2):96-103. PubMed ID: 2129420
    [Abstract] [Full Text] [Related]

  • 7. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES, Lam JS.
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [Abstract] [Full Text] [Related]

  • 8. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ, Gerçeker AA, Koles NL, Pollack M, Pier GB.
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [Abstract] [Full Text] [Related]

  • 9. Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis.
    Hemachandra S, Kamboj K, Copfer J, Pier G, Green LL, Schreiber JR.
    Infect Immun; 2001 Apr; 69(4):2223-9. PubMed ID: 11254577
    [Abstract] [Full Text] [Related]

  • 10. Immunization with Pseudomonas aeruginosa high-molecular-weight polysaccharides prevents death from Pseudomonas burn infections in mice.
    Pollack M, Pier GB, Prescott RK.
    Infect Immun; 1984 Feb; 43(2):759-60. PubMed ID: 6420347
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of cell wall Pseudomonas aeruginosa vaccines for protection against experimental pneumonia.
    Pennington JE, Pier GB.
    Rev Infect Dis; 1983 Feb; 5 Suppl 5():S852-7. PubMed ID: 6419311
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pseudomonas aeruginosa immunotype 5 polysaccharide-toxin A conjugate vaccine.
    Cryz SJ, Furer E, Sadoff JC, Germanier R.
    Infect Immun; 1986 Apr; 52(1):161-5. PubMed ID: 3082756
    [Abstract] [Full Text] [Related]

  • 14. Opsonic and protective activity of five human IgM monoclonal antibodies reactive with lipopolysaccharide antigen of Pseudomonas aeruginosa.
    Collins MS, Ladehoff DK, Mehton NS, Noonan JS.
    FEMS Microbiol Immunol; 1990 Dec; 2(5-6):263-8. PubMed ID: 2127368
    [Abstract] [Full Text] [Related]

  • 15. Lipopolysaccharide and high-molecular-weight polysaccharide serotypes of Pseudomonas aeruginosa.
    Pier GB, Thomas DM.
    J Infect Dis; 1982 Feb; 145(2):217-23. PubMed ID: 6798136
    [Abstract] [Full Text] [Related]

  • 16. Cloning and surface expression of Pseudomonas aeruginosa O antigen in Escherichia coli.
    Goldberg JB, Hatano K, Meluleni GS, Pier GB.
    Proc Natl Acad Sci U S A; 1992 Nov 15; 89(22):10716-20. PubMed ID: 1279692
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. High-molecular-weight polysaccharide antigen from Pseudomonas aeruginosa immunotype 2.
    Pier GB, Sidberry HF, Sadoff JC.
    Infect Immun; 1981 Nov 15; 34(2):461-8. PubMed ID: 6171520
    [Abstract] [Full Text] [Related]

  • 19. Outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model.
    Matthews-Greer JM, Gilleland HE.
    J Infect Dis; 1987 Jun 15; 155(6):1282-91. PubMed ID: 3033095
    [Abstract] [Full Text] [Related]

  • 20. Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and antilipopolysaccharide.
    Cryz SJ, Fürer E, Germanier R.
    Infect Immun; 1983 Mar 15; 39(3):1072-9. PubMed ID: 6404817
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.